Sandoz Inc. vs. Acerta Pharma B.V. et al.

Explore the PTAB proceeding IPR2023-00478 filed by Sandoz Inc. on 2023-02-03. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00478

Filing Date

2023-02-03

Accorded Filing Date

2023-02-03

Institution Decision Date

2023-08-07

Last Modified Date

—

Proceeding Type

IPR

Termination Date

2023-08-07

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Sandoz Inc.

Represented By

Wong, Jovialet al

Patent Owner / Respondent

Acerta Pharma B.V. et al.

Represented By

Fisher, Stanleyet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 15112968

Respondent Patent Number 10272083

External Links

Espacenet

Google Patents

Respondent Inventor Ahmed Hamdy et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

84 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Morgan, Lewis & Bockius LLP (PH)

Customer Number 28977

Address 2222 Market Street, Philadelphia, PA, 19103, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
31066	Gary Williams	650-843-7501
37386	Michael Lyons	650-843-7507
39266	Soyeon Laub	714-830-0512
39876	Scott Williams	301-398-5078
39951	Douglas Crisman	650-843-4000
40506	Louis Beardell Jr	215-963-5067
40930	Robert Busby Jr	202-739-5970
41040	Robert Goodell	202-739-5549
41796	Andrew Gray Iv	650-843-4000
42223	Jason White	312-321-4200
42813	Brett Lovejoy	415-442-1211
42837	Jeffry Mann	415-442-1000
43378	Collin Park	202-739-3000
44146	Brent Hawkins	415-442-1000
45645	Dion Bregman	650-843-4000
46552	Robert Beyers	650-843-7528
46692	Ramyar Farid	202-739-5195
48714	Patrick Alban	301-398-1041
50801	Robert Smyth	202-739-5139
50862	Ahren Hsu-Hoffman	650-843-4000
50891	Jeffrey Killian	202-739-5592
51793	Mark Hayman	617-951-8440
52115	Jeremy Peterson	202-871-0140
53615	Nathan Smith	949-757-6018
55001	Olga Berson	310-907-9045
55202	Jason Gettleman	650-843-7593
55293	Ari Indik	215-864-7138
56038	Yong Lu	301-398-1277
56890	Christopher Betti	312-324-1449
57765	Yalei Sun	650-843-7558
58240	Shannon Carroll	301-398-2582
58686	Jacob Oyloe	301-398-5043
58729	Louis-Vu Nguyen	415-442-1303
58752	John Hemmer	215-963-4816
59462	Brad Wilson	312-324-1103
59649	Tae Woong Koo	650-843-7246
60472	M. Hales	714-830-0514
60711	Richard Leung	215-963-5082
60768	Kwame Mensah	301-398-0972
61673	Albert Lee	714-830-0600
61841	Kenneth Cheney	714-830-0526
62510	Ben You	202-429-0020
62741	Shaobin Zhu	206-839-4894
63115	Michael Ryan	610-574-1318
63133	Stephen Altieri	617-951-8525
63219	Kimberly Braslow	443-571-4898
63328	Clay Hawes	7034154864
64526	Janice Logan	202-439-5234
65111	Rebecca Dise	312-616-5600
65210	Christina Macdougall	415-442-1277
65592	Liying Sun	650-843-7215
66020	Anita Melikian	1-978-670-8027
66595	Daniel Tarr	215-963-4995
66838	Jianbai Wang	650-843-7843
67908	Yingying Zhou	415-442-1214
68345	Danny Mansour	714-830-0600
68487	Alia Orbin	610-390-7234
69096	Toyomi Ohara	202-739-3000
69185	Kakoli Mitra	141-534-47151
69316	Byung Cheol Kwak	617-341-7264
69333	Hosang Lee	202-937-5142
70067	Sujohn Das	713-890-5792
70236	Kalpesh Upadhye	202-739-5157
70711	Benjamin Pezzner	650-843-4000
70871	Andrew Antczak	215-963-5000
71054	Yon Sohn	858-587-1121
71064	David Bernstein	650-843-4000
71076	Wan-Shoon Lo	312-984-5810
71265	Archis Ozarkar	713-485-7310
71397	Alexander Stein	650-843-7278
71751	Moreshwar Vaze	617-341-7952
71964	Joel Aldrich	301-398-0932
73696	Chantal Edde	215-963-5656
75470	Sara Sims	215-963-5630
75669	Andrew Dietrick	570-906-0745
76118	James Eaton	301-398-0000
77918	Alicia Fraind	215-972-8594
79300	Evelyn Chou	415-442-1609
79663	Kathryn Chesnick	570-878-2384
79760	Xiaoqian Li	650-843-7853
80622	Corey Moore	617-341-7852
81935	Jia Jie Tang	617-951-8000
81982	Corine Martineau	215-963-5030
82004	Isabella Couture	316-680-1931

Proceeding Documents

Denying Institution of Inter Partes Review 35 U.S.C. 314 DECISION

2023-08-07 FILING PARTY: BOARD

Download

Petitioner's Updated Exhibit List (as of 08-08-2023) NOTICE

2023-06-08 FILING PARTY: PETITIONER

Download

1046

Ex. 1046 - COMPLAINT Acerta Pharma B.V. et al. Case No. 1:22-cv-00164-GBW, Dkt. 1 (D. Del. Feb. 4, 2022)v. Sandoz Inc., Exhibit

2023-06-08 FILING PARTY: PETITIONER

Download

Petitioner’s Authorized Response In Opposition To Patent Owner’s Motion For Leave To File Request For Certificate Of Correction OTHER

2023-06-08 FILING PARTY: PETITIONER

Download

Patent Owner's Authorized Sur-Reply OTHER

2023-06-02 FILING PARTY: PATENT OWNER

Download

Sandoz Inc. vs. Acerta Pharma B.V. et al.

Proceeding Overview

Parties & Counsel

Petitioner

Sandoz Inc.

Represented By

Patent Owner / Respondent

Acerta Pharma B.V. et al.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Denying Institution of Inter Partes Review 35 U.S.C. 314 DECISION

Petitioner's Updated Exhibit List (as of 08-08-2023) NOTICE

Ex. 1046 - COMPLAINT Acerta Pharma B.V. et al. Case No. 1:22-cv-00164-GBW, Dkt. 1 (D. Del. Feb. 4, 2022)v. Sandoz Inc., Exhibit

Petitioner’s Authorized Response In Opposition To Patent Owner’s Motion For Leave To File Request For Certificate Of Correction OTHER

Patent Owner's Authorized Sur-Reply OTHER

Petitioner's Authorized Reply to POPR REPLYTOOPP

EX2010 - Merck Bloomberg Report Exhibit

Patent Owner's Amended Exhibit List NOTICE

Patent Owner's Motion for Leave MOTION

Exhibit 3003 Exhibit

EX2007 - S7520, Senate Report, June 25, 2004 Exhibit

Patent Owner's Preliminary Response POPR

Patent Owner's Motion To Seal MOTION

EX2009 - Acerta History Report Exhibit

EX2006 - 108th Congress, House Report H.R. 2391 Exhibit

EX2008 - Acerta Company Report Exhibit

EX2005 - Claim Construction Stipulation, Acerta Pharma, et al. v. Alembic Pharmaceuticals Ltd, et al., No. 22-154-GBW-SRF, Dkt No 1083 (D. Del. Mar. 13, 2023) Exhibit

EX2001 - Defendants' Invalidity Contentions Exhibit

Exhibit 3002 Exhibit

Order: Granting Petitioners Motion for Admission Pro Hac Vice of Charles B. Klein and Eimeric Reig-Plessis ORDER

Exhibit 3001 Exhibit

Petitioner’s Unopposed Motion For Pro Hac Vice Admission Of Charles B. Klein And Eimeric Reig-Plessis MOTION

Ex. 1045 - Declaration Of Eimeric Reig-Plessis In Support Of Motion For PHV Admission Exhibit

Petitioner’s Unopposed Motion For Pro Hac Vice Admission Of Charles B. Klein And Eimeric Reig-Plessis MOTION

Ex. 1044 - Declaration Of Charles B. Klein In Support Of Motion For PHV Admission Exhibit

Notice : Power of Attorney for Patent Owner NOTICE

Notice : Mandatory Notices by Patent Owner NOTICE

Notice : Power of Attorney for Patent Owner NOTICE

Notice : Mandatory Notices by Patent Owner NOTICE

Notice: Notice filing date accorded NOTICE

Ex. 1022 - Simon Rule, et al., Exhibit

Ex. 1039 - TASIGNA® (nilotinib) Prescribing Information Exhibit

Petition : as filed PETITION

Ex. 1029 - Erica K. Evans, et al. Exhibit

Ex. 1019 - Claire V. Hutchinson, et al. Exhibit

Ex. 1023 - Prosecution History of U.S. Patent No. 9,758,524 (Part 1) Exhibit

Ex. 1027 - U.S. Food and Drug Administration, Guidance for Industry Exhibit

Ex. 1013 - U.S. Provisional Application No. 62/035,777 Exhibit

Ex. 1004 - Prosecution History of U.S. Patent No. 10,272,083 (Part 1) Exhibit

Ex. 1005 - U.S. Patent No. 9,758,524 to Barf, et al. Exhibit

Ex. 1033 - Toshio Yoshizawa, et al., Exhibit

Ex. 1006 - PCT International Publication No. WO2013/010868 to Barf, et al. Exhibit

Ex. 1010 - John C. Byrd, et al. Exhibit

Ex. 1034 - Plaintiffs’ Initial Infringement Contentions to Def Sandoz Inc. Exhibit

Ex. 1004 - Prosecution History of U.S. Patent No. 10,272,083 (Part 5) Exhibit

Ex. 1007 - U.S. Provisional Application No. 61/509,397 to Barf, et al. Exhibit

Ex. 1004 - Prosecution History of U.S. Patent No. 10,272,083 (Part 3) Exhibit

Ex. 1011 - U.S. Provisional Application No. 61/929,742 Exhibit

Notice : Executed Power of Attorney - Sandoz, Inc. NOTICE

Ex. 1043 - Yan Bao, et al. Exhibit

Ex. 1004 - Prosecution History of U.S. Patent No. 10,272,083 (Part 6) Exhibit

Ex. 1025 - U.S. Patent No. 7,732,454 Exhibit

Ex. 1002 - Declaration Of John P. Fruehauf, M.D., Ph.D. Exhibit

Ex. 1023 - Prosecution History of U.S. Patent No. 9,758,524 (Part 3) Exhibit

Ex. 1041 - LYNPARZA™ (olaparib) Prescribing Information Exhibit

Ex. 1004 - Prosecution History of U.S. Patent No. 10,272,083 (Part 2) Exhibit

Ex. 1009 - Ranjana H. Advani, et al. Exhibit

Ex. 1036 - Jan de Jong, et al. Exhibit

Ex. 1035 - CALQUENCE® (acalabrutinib) Prescribing Information Exhibit

Ex. 1020 - Jennifer R. Brown, et al. Exhibit

Ex. 1042 - Betty Y. Chang, et al. Exhibit

Ex. 1004 - Prosecution History of U.S. Patent No. 10,272,083 (Part 4) Exhibit

Ex. 1038 - ZYDELIG® (idelalisib) Prescribing Information Exhibit

Ex. 1003 -Declaration Of Sylvia D. Hall-Ellis, Ph.D. Exhibit

Ex. 1012 - U.S. Provisional Application No. 61/974,665 Exhibit